Published in J Exp Med on October 19, 1998
Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J Exp Med (1999) 3.78
Ectopic lymphoid tissues and local immunity. Semin Immunol (2008) 2.18
Tumor necrosis factor (TNF) protects resistant C57BL/6 mice against herpes simplex virus-induced encephalitis independently of signaling via TNF receptor 1 or 2. J Virol (2006) 1.27
Ontogeny of stromal organizer cells during lymph node development. J Immunol (2010) 1.20
Critical roles for IFN-beta in lymphoid development, myelopoiesis, and tumor development: links to tumor necrosis factor alpha. Proc Natl Acad Sci U S A (2003) 1.14
A stimulus-specific role for CREB-binding protein (CBP) in T cell receptor-activated tumor necrosis factor alpha gene expression. Proc Natl Acad Sci U S A (2000) 1.05
Tumor necrosis factor alpha and interleukin-6 facilitate corneal lymphangiogenesis in response to herpes simplex virus 1 infection. J Virol (2014) 0.92
Mechanisms of tumor necrosis factor α antagonist-induced lupus in a murine model. Arthritis Rheumatol (2015) 0.84
Association of -1087 IL10 and -308 TNFA gene polymorphisms with serological markers of coeliac disease. J Clin Immunol (2003) 0.80
Autoreactive preplasma cells break tolerance in the absence of regulation by dendritic cells and macrophages. J Immunol (2012) 0.80
Stromal Fibroblasts in Tertiary Lymphoid Structures: A Novel Target in Chronic Inflammation. Front Immunol (2016) 0.76
Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature (1988) 9.17
Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science (1994) 7.10
A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell (1996) 5.97
Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur J Immunol (1991) 5.38
A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature (1998) 4.52
Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature (1994) 4.36
Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Immunity (1997) 3.99
Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J Immunol (1995) 3.69
Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers. Science (1996) 3.24
Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs. J Exp Med (1996) 2.93
Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate. Immunity (1995) 2.55
Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur J Immunol (1997) 2.53
Affinity maturation without germinal centres in lymphotoxin-alpha-deficient mice. Nature (1996) 2.43
B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin alpha-dependent fashion. J Exp Med (1998) 2.32
The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med (1996) 1.96
Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling. J Exp Med (1996) 1.93
Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double-deficient mice. Int Immunol (1996) 1.83
Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice. Eur J Immunol (1997) 1.80
The sequential role of lymphotoxin and B cells in the development of splenic follicles. J Exp Med (1998) 1.72
Separation of events mediating B cell proliferation and Ig production by using T cell membranes and lymphokines. J Immunol (1990) 1.60
Newly produced virgin B cells migrate to secondary lymphoid organs but their capacity to enter follicles is restricted. Eur J Immunol (1987) 1.30
Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization. Int Immunol (1997) 1.29
Signaling thresholds and interclonal competition in preimmune B-cell selection. Immunol Rev (1997) 1.20
Gene targeting in C57BL/6 ES cells. Successful germ line transmission using recipient BALB/c blastocysts developmentally matured in vitro. Nucleic Acids Res (1997) 1.17
Outer periarteriolar lymphoid sheath arrest and subsequent differentiation of both naive and tolerant immunoglobulin transgenic B cells is determined by B cell receptor occupancy. J Exp Med (1997) 1.13
Spontaneous follicular exclusion of SHP1-deficient B cells is conditional on the presence of competitor wild-type B cells. J Exp Med (1998) 1.12
Regulation of CD40 ligand expression and use of recombinant CD40 ligand for studying B cell growth and differentiation. Semin Immunol (1994) 1.11
Population kinetics of rat peripheral B cells. J Exp Med (1988) 1.01
Characterization of new rat anti-mouse IgE monoclonals and their use along with chimeric IgE to further define the site that interacts with Fc epsilon RII and Fc epsilon RI. Mol Immunol (1991) 0.99
Crucial role of tumor necrosis factor receptor 1 expression on nonhematopoietic cells for B cell localization within the splenic white pulp. J Exp Med (1998) 0.99
Functional comparisons of different tumour necrosis factor receptor/IgG fusion proteins. Cytokine (1995) 0.88
Sites of B lymphocyte selection, activation, and tolerance in spleen. J Exp Med (1997) 0.84
A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med (1972) 7.47
A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature (2000) 6.89
A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci U S A (1998) 5.94
A receptor for antibody on B lymphocytes. II. Immunochemical and electron microscopy characteristics. J Exp Med (1972) 4.63
Specific inactivation of thymus-derived (T) and non-thymus-derived (B) lymphocytes by 125I-labelled antigen. Nat New Biol (1971) 4.55
A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature (1998) 4.52
Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science (2000) 4.41
A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J Immunol Methods (1983) 4.39
Mechanism of eosinophilia. II. Role of the lymphocyte. J Exp Med (1970) 4.34
Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature (1991) 4.04
Induction of self-tolerance in mature peripheral B lymphocytes. Nature (1989) 4.02
Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc Natl Acad Sci U S A (2000) 3.80
Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J Exp Med (1999) 3.78
Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells. J Exp Med (1998) 3.72
In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines. J Exp Med (1999) 3.69
A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol (2000) 3.44
Mechanism of eosinophilia. I. Factors affecting the eosinophil response of rats to Trichinella spiralis. J Exp Med (1970) 3.40
Chemokines as regulators of T cell differentiation. Nat Immunol (2001) 3.37
A coordinated change in chemokine responsiveness guides plasma cell movements. J Exp Med (2001) 3.36
IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity (1996) 3.23
Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell (1993) 3.09
T cell-dependent suppression of an anti-hapten antibody response. Transplant Rev (1975) 3.06
Interaction between lymphocytes in immune responses. Cell Immunol (1971) 3.03
BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity (2000) 2.79
Cell-to-cell interaction in the immune response. X. T-cell-dependent suppression in tolerant mice. J Exp Med (1974) 2.77
DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity (2000) 2.75
Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity (2000) 2.64
Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur J Immunol (1997) 2.53
Cell interactions in the immune response in vitro. IV. Comparison of the effects of antigen-specific and allogeneic thymus-derived cell factors. J Exp Med (1972) 2.48
Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity (1998) 2.42
Mycobacterium leprae antigens involved in human immune responses. I. Identification of four antigens by monoclonal antibodies. J Immunol (1985) 2.40
Splenic T zone development is B cell dependent. J Exp Med (2001) 2.35
Chemokine Up-regulation and activated T cell attraction by maturing dendritic cells. Science (1999) 2.34
Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity (1997) 2.34
Structure of domain 1 of rat T lymphocyte CD2 antigen. Nature (1991) 2.31
Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. J Immunol (1994) 2.29
Cell division regulates the T cell cytokine repertoire, revealing a mechanism underlying immune class regulation. Proc Natl Acad Sci U S A (1998) 2.26
Nitrous oxide reductase from denitrifying Pseudomonas perfectomarina. Purification and properties of a novel multicopper enzyme. Eur J Biochem (1985) 2.15
Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med (1994) 2.15
A cellular calculus for signal integration by T cells. Nat Immunol (2000) 2.09
Self-tolerance checkpoints in B lymphocyte development. Adv Immunol (1995) 1.97
Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen. Science (1991) 1.97
The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med (1996) 1.96
Cell interactions in the immune response in vitro. 3. Specific collaboration across a cell impermeable membrane. J Exp Med (1972) 1.96
Circulating T and B lymphocytes of the mouse. II. Lifespan. Cell Immunol (1973) 1.94
Bile duct cysts in adults. Br J Surg (2004) 1.89
Receptor for antibody-antigen complexes used to separate T cells from B cells. Nat New Biol (1972) 1.87
Immunoreactivity of a 70 kD protein purified from Mycobacterium bovis Bacillus Calmette-Guerin by monoclonal antibody affinity chromatography. J Exp Med (1986) 1.78
Homology of the 70-kilodalton antigens from Mycobacterium leprae and Mycobacterium bovis with the Mycobacterium tuberculosis 71-kilodalton antigen and with the conserved heat shock protein 70 of eucaryotes. Infect Immun (1989) 1.75
Induction of IgE-secreting cells and IgE isotype-specific suppressor T cells in the respiratory lymph nodes of rats in response to antigen inhalation. Cell Immunol (1985) 1.73
Stent-assisted mechanical recanalization for treatment of acute intracerebral artery occlusions. Stroke (2010) 1.69
Mechanisms for eosinophilic and neutrophilic leucocytoses. Br Med J (1971) 1.66
Tumor necrosis factor: a master-regulator of leukocyte movement. Immunol Today (2000) 1.65
Relationship between Fc receptors, antigen-binding sites on T and B cells, and H-2 complex-associated determinants. J Exp Med (1975) 1.58
Cell division number regulates IgG1 and IgE switching of B cells following stimulation by CD40 ligand and IL-4. Eur J Immunol (1998) 1.58
Flow cytometric analysis of cell division history using dilution of carboxyfluorescein diacetate succinimidyl ester, a stably integrated fluorescent probe. Methods Cell Biol (2001) 1.58
A model of immune regulation as a consequence of randomized lymphocyte division and death times. Proc Natl Acad Sci U S A (2007) 1.57
Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J Exp Med (1997) 1.56
Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity (2001) 1.53
How intravenous immunoglobulin is used in clinical practice: audits of two Sydney teaching hospitals. Intern Med J (2007) 1.52
Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocyte recruitment. J Exp Med (2001) 1.51
Isolation and characterization of transposon Tn5-induced mutants of Pseudomonas perfectomarina defective in nitrous oxide respiration. J Bacteriol (1985) 1.51
Mobile stroke unit for diagnosis-based triage of persons with suspected stroke. Neurology (2012) 1.49
Specific collaboration between T and B lymphocytes across a cell impermeable membrane in vitro. Nat New Biol (1972) 1.49
Mechanism of eosinophilia. 3. Suppression of eosinophilia by agents known to modify immune responses. Blood (1970) 1.48
Chemokines in lymphopoiesis and lymphoid organ development. Curr Opin Immunol (2001) 1.47
Cell-to-cell interaction in the immune response. VII. Requirement for differentiation of thymus-derived cells. J Exp Med (1971) 1.46
Microsatellite instability in colorectal cancer. Br J Surg (2006) 1.46
Illegitimate switch recombinations are present in approximately half of primary myeloma tumors, but do not relate to known prognostic indicators or survival. Blood (2001) 1.45
Microglia induce CD4 T lymphocyte final effector function and death. J Exp Med (1996) 1.44
A single-cell pedigree analysis of alternative stochastic lymphocyte fates. Proc Natl Acad Sci U S A (2009) 1.42
Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF. J Immunol (2001) 1.42
Switching to IgG3, IgG2b, and IgA is division linked and independent, revealing a stochastic framework for describing differentiation. J Immunol (1999) 1.41
Quantitative analysis of lymphocyte differentiation and proliferation in vitro using carboxyfluorescein diacetate succinimidyl ester. Immunol Cell Biol (1999) 1.39
Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment. Blood (2001) 1.37
An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum. J Exp Med (1998) 1.36
A subpopulation of T cells bearing Fc receptors. J Immunol (1975) 1.35
Defects in cytochrome cd1-dependent nitrite respiration of transposon Tn5-induced mutants from Pseudomonas stutzeri. Arch Microbiol (1988) 1.34
Lymphocyte homing: the scent of a follicle. Curr Biol (1997) 1.34
Multiple transcription factors of the FNR family in denitrifying Pseudomonas stutzeri: characterization of four fnr-like genes, regulatory responses and cognate metabolic processes. Mol Microbiol (1999) 1.34